Cited by

• PGE₁-Containing Protocols Generate Mature (Leukemia-Derived) Dendritic Cells Directly from Leukemic Whole Blood.

  Amberger DC, Doraneh-Gard F, Gunsilius C, Weinmann M, Möbius S, Kugler C, Rogers N, Böck C, Ködel U, Werner JO, Krämer D, Eiz-Vesper B, Rank A, Schmid C, Schmetzer HM. Amberger DC, et al. Int J Mol Sci. 2019 Sep 17;20(18):4590. doi: 10.3390/ijms20184590. Int J Mol Sci. 2019. PMID: 31533251 Free PMC article.
• Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages.

  Lara-Guzmán OJ, Gil-Izquierdo Á, Medina S, Osorio E, Álvarez-Quintero R, Zuluaga N, Oger C, Galano JM, Durand T, Muñoz-Durango K. Lara-Guzmán OJ, et al. Redox Biol. 2018 May;15:1-11. doi: 10.1016/j.redox.2017.11.017. Epub 2017 Nov 22. Redox Biol. 2018. PMID: 29195136 Free PMC article.
• Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.

  Cawello W, Schweer H, Müller R, Bonn R, Seyberth HW. Cawello W, et al. Eur J Clin Pharmacol. 1994;46(3):275-7. doi: 10.1007/BF00192562. Eur J Clin Pharmacol. 1994. PMID: 8070511 Clinical Trial.
• Synthesis of prostaglandin E(1) phosphate derivatives and their encapsulation in biodegradable nanoparticles.

  Takeda M, Maeda T, Ishihara T, Sakamoto H, Yuki K, Takasaki N, Nishimura F, Yamashita T, Tanaka K, Takenaga M, Igarashi R, Higaki M, Yamakawa N, Okamoto Y, Ogawa H, Otsuka M, Mizushima Y, Mizushima T. Takeda M, et al. Pharm Res. 2009 Jul;26(7):1792-800. doi: 10.1007/s11095-009-9891-5. Epub 2009 May 5. Pharm Res. 2009. PMID: 19415470
• Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.

  Ishihara T, Takeda M, Sakamoto H, Kimoto A, Kobayashi C, Takasaki N, Yuki K, Tanaka K, Takenaga M, Igarashi R, Maeda T, Yamakawa N, Okamoto Y, Otsuka M, Ishida T, Kiwada H, Mizushima Y, Mizushima T. Ishihara T, et al. Pharm Res. 2009 Oct;26(10):2270-9. doi: 10.1007/s11095-009-9943-x. Epub 2009 Jul 25. Pharm Res. 2009. PMID: 19633820